Towercrest Capital Management Soma Logic, Inc. Transaction History

Towercrest Capital Management

  • $630 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023
BUY
$2.1 - $3.36 $190,207 - $304,332
90,575 New
90,575 $209,000

Others Institutions Holding SLGC

# of Institutions
3
Shares Held
7.48M
Call Options Held
0
Put Options Held
0
View Full List

About SomaLogic, Inc.

SLGC Quotes by TradingView
  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Towercrest Capital Management Portfolio

Follow Towercrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Towercrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email